Oliver Seifert is a senior scientist in the laboratory of Roland Kontermann at the University of Stuttgart and leads the bispecific antibody group. He is an expert in the field of antibody engineering with more than 15 years experience. His scientific research covers development and characterization of novel antibodies specific for therapeutic applications with a focus on the development of bi- and multispecific antibodies for tumor therapy. Oliver studied Technical Biology and obtained his doctoral degree from the University of Stuttgart.